Davis Scott G. 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Apr 26, 2022
Insider Transaction Report
Form 4
Davis Scott G.
DirectorCEO
Transactions
- Sale
Common Stock
2022-04-20$2.62/sh−4,043$10,583→ 73,815 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person on April 20, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on February 22, 2022.
- [F2]The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.61 to $2.63, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.